Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Charline Potier"'
Autor:
Fawaz Alzaid, Jean‐Baptiste Julla, Marc Diedisheim, Charline Potier, Louis Potier, Gilberto Velho, Bénédicte Gaborit, Philippe Manivet, Stéphane Germain, Tiphaine Vidal‐Trecan, Ronan Roussel, Jean‐Pierre Riveline, Elise Dalmas, Nicolas Venteclef, Jean‐François Gautier
Publikováno v:
EMBO Molecular Medicine, Vol 12, Iss 10, Pp 1-12 (2020)
Abstract Early in the COVID‐19 pandemic, type 2 diabetes (T2D) was marked as a risk factor for severe disease and mortality. Inflammation is central to the aetiology of both conditions where variations in immune responses can mitigate or aggravate
Externí odkaz:
https://doaj.org/article/7c72d6f547d64ae5b2a37caae2a48163
Autor:
Sylvain Baulande, Corinne Blugeon, Jeremie Boucher, Marc Diedisheim, Charline Potier, Daniel Lindén, Alexandre Humbert, Lucie Orliaguet, Jessica Michieletto, François Fenaille, Judith Charbit, Laura G. Baudrin, Fawaz Alzaid, Akila Hamimi, Jean-Pierre Riveline, Jennifer Rieusset, Jean-Baptiste Julla, Florence Castelli, Sonia Lameiras, Raphaelle Ballaire, Sophie Lemoine, Jean-François Gautier, Nicolas Venteclef, Patricia Legoix, Tina Ejlalmanesh, Antoine Soprani
Over the course of diet-induced obesity (DIO), adipose tissue macrophage (ATM) populations transition from highly oxidative and protective to highly inflammatory and metabolically deleterious. Here, we demonstrate that the Interferon Regulatory Facto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::79a9d2054c1b5e0ad804d29bfc8a111a
https://doi.org/10.21203/rs.3.rs-477956/v1
https://doi.org/10.21203/rs.3.rs-477956/v1
Autor:
Charline Potier, Manivet P, Louis Potier, Tiphaine Vidal-Trecan, Jean-Pierre Riveline, Elise Dalmas, Stéphane Germain, Jean-Baptiste Julla, Bénédicte Gaborit, Ronan Roussel, Gilberto Velho, Jean-François Gautier, Nicolas Venteclef, Fawaz Alzaid, Marc Diedisheim
BackgroundEarly in the COVID-19 pandemic type 2 diabetes (T2D) was marked as a risk factor of severe disease and mortality. Inflammation is central to the aetiology of both conditions where variations in immune responses have the potential to mitigat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e1974b73b59ad5e3ef5c3392fbdbf97
Autor:
Charline Potier, Tiphaine Vidal-Trecan, Jean-François Gautier, Bénédicte Gaborit, Ronan Roussel, Fawaz Alzaid, Stéphane Germain, Gilberto Velho, Marc Diedisheim, Jean-Baptiste Julla, Jean-Pierre Riveline, Nicolas Venteclef, Louis Potier, Philippe Manivet, Elise Dalmas
Publikováno v:
EMBO Molecular Medicine
EMBO Molecular Medicine, Wiley Open Access, 2020, 12 (10), pp.e13038. ⟨10.15252/emmm.202013038⟩
EMBO Molecular Medicine, Vol 12, Iss 10, Pp n/a-n/a (2020)
EMBO Molecular Medicine, 2020, 12 (10), pp.e13038. ⟨10.15252/emmm.202013038⟩
EMBO Molecular Medicine, Wiley Open Access, 2020, 12 (10), pp.e13038. ⟨10.15252/emmm.202013038⟩
EMBO Molecular Medicine, Vol 12, Iss 10, Pp n/a-n/a (2020)
EMBO Molecular Medicine, 2020, 12 (10), pp.e13038. ⟨10.15252/emmm.202013038⟩
International audience; Early in the COVID-19 pandemic, type 2 diabetes (T2D) was marked as a risk factor for severe disease and mortality. Inflammation is central to the aetiology of both conditions where variations in immune responses can mitigate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9bc3433a3cc6c2b24b3e97dfd1fdb01c